Apoptosis and antiangiogonesis. Treatment principles of gynecologic oncology;Apoptose und antiangiogenese. Therapieprinzipien der gynäkologischen onkologie

Gynakologe

Volumn 37, Issue 3, 2004, Pages 222-229

  Meinhold Heerlein, I ^a   Maass, N ^a   Jonat, W ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Angiogenesis; Apoptosis; Breast cancer; Gynecologic oncology; Molecular target

Indexed keywords

2 METHOXYESTRADIOL; AE 941; ANGIOGENESIS INHIBITOR; AVASTATIN; BEVACIZUMAB; CELECOXIB; CILENGITIDE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ENZASTAURIN; ETOPOSIDE; FLUOROURACIL; GEFITINIB; GEMCITABINE; GENISTEIN; HALOFUGINONE; HERZEPTIN; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 12; LENALIDOMIDE; METHOTREXATE; MONOCLONAL ANTIBODY LM 609; PACLITAXEL; PROTEIN BCL 2; PROTEIN KINASE C INHIBITOR; TEMPOSTATIN; THALIDOMID; THALIDOMIDE; TOPOTECAN; TRASTUZUMAB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; GYNECOLOGIC CANCER; HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW;

EID: 2442640065     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-004-1495-x     Document Type: Review

References (20)

1. Bauknecht T, Meinhold-Heerlein I (2001) Apoptose, Angiogenese und molekulare Pharmakologie. In: Beckmann MW, Dall P, Fasching PA, Kruessel J-L, Niederacher D, Tutschek B (eds) Molekulare Medizin in der Frauenheilkunde. Steinkopff-Verlag, Darmstadt
2. Bruns CJ, Liu W, Davis DW et al. (2000) Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89: 488-499
3. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257
4. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776
5. Inoue K, Slaton JW, Davis DW et al. (2000) Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel. Clin Cancer Res 6: 2635-2643
6. Izumi Y, di Tomaso E, Hooper A et al. (2003) Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts. Cancer Res 63: 747-751
7. Jordan VC (2003) Tamoxifen: a most unlikely pioneering medicine. Nature Rev 2: 205-213
8. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256: 42-49
9. Kaufmann SH, Hengartner MO (2001) Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11: 526-534
10. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nature Rev Cancer 2: 727-739
11. Klement G, Baruchel S, Rak J et al. (2000) Continous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 105: 15-24
12. Kozin SV, Boucher Y, Hicklin DJ, Bohlen P, Jain RK, Suit HD (2001) Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res 61: 39-44
13. Meinhold-Heerlein I, Krajewska M, Gruenn U, Schlebusch H, Bauknecht T, Reed JC (2001) TRAIL receptor expression and TRAIL-responses in ovarian cancer. Proc Am Assoc Cancer Res 42: 313
14. Meinhold-Heerlein I, Stenner-Liewen F, Liewen H et al. (2001) Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. Am J Pathol 158: 1335-1344
15. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
16. Prewett M, Huber J, Li Y et al. (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59: 5209-5218
17. Reed JC (2003) Apoptosis-targeted therapies for cancer. Cancer Cell 3: 17-22
18. Welsh JB, Zarrinkar PP, Sapinoso LM et al. (2001) Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 98: 1176-1181
19. Wu GS, Kim K, el-Deiry WS (2000) KILLER/DRS, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death. Adv Exper Med Biol 465: 143-151
20. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248